| Literature DB >> 35022164 |
Cila Umat1, Azhar Bin Talib2, Normah Che Din3, Nor Haniza Abdul Wahat3.
Abstract
INTRODUCTION: Prader-Willi Syndrome (PWS) is one of the rare diseases involving genetics and affects various body systems. The disease is known due to the absence of paternal genes on chromosome 15q11-q13. Multisystem complex conditions require interdisciplinary healthcare treatment. However, to the best of our knowledge, there is little evidence of an established successful model of an interdisciplinary approach in managing rare diseases like PWS. METHODS AND ANALYSIS: The scoping review process follows the five-staged Arksey and O'Malley (2005) methodology framework excluding the optional consultation stage (stage 6): the definition of the research questions (step 1); the eligibility criteria and search strategy are defined (stage 2); the study selection process based on the eligibility criteria identified will follow (stage 3); a framework developed for this review will then inform the extraction and charting of data from the included studies (step 4) and results will be aggregated and summarised with criteria relevant for health professionals and policymakers (stage 5). We will search for electronic databases (MEDLINE/PubMed, Scopus, Web of Science), grey literature sources and critical studies' reference lists to determine the appropriate inclusion criteria. Three researchers will review all abstracts and full-text studies for inclusion. ETHICS AND DISSEMINATION: This scoping review methodology does not require ethical approval since it aims to synthesise information from available publications. A scoping review article will be submitted for publication to a scientific journal following this protocol. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: nutrition & dietetics; paediatric clinical genetics & dysmorphology; paediatric endocrinology; protocols & guidelines; quality in health care
Mesh:
Year: 2022 PMID: 35022164 PMCID: PMC8756288 DOI: 10.1136/bmjopen-2020-047638
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Data extraction framework
| Main category | Subcategory | Description |
| 1. Authors | ||
| 2. Title | ||
| 3. Journal | ||
| 4. Year of publication | ||
| 5. Objectives of the review | Outline the objectives of the scoping study | |
| 6. Type of review | State the type of review of the article selected, such as narrative, scoping, systematic, meta-analysis or other types of review | |
| 7. Number of studies included in the review | Indicate the number of primary studies included in the review | |
| 8. Years of publication of the studies included in the review | Specify the range of the years of publications of the studies included in the review | |
| 9. Type of studies included in the review | State the specific types of studies included for the review (eg, case study, case–control, cross-sectional, random control trials (RCTs), etc) | |
| 10. Characteristics of the intervention(s) |
Intervention types Method of intervention delivery Duration and intensity of the intervention |
State the type(s) of the interventions The description of how the intervention was done and who provided the intervention State the duration of intervention and its frequency |
| 11. Biopsychosocial profiles of PWS children, adolescents and adults | Describe the strengths and weaknesses of PWS individuals in their biological profiles, physical functions, behavioural characteristics, nutritional status and cognitive profiles | |
| 12. Multidimensional measurements of functions | Describe instruments commonly used to screen or measure multidimensional functioning in PWS children to adults | |
| 13. The setting of the intervention(s) | State whether the interventions were performed in school-based, family-based or community-based settings | |
| 14. Outcomes of the intervention studies | Reported outcomes of the interventions done in the review (eg, weight, height, BMI, behaviour, cognitive function) | |
| 15. Effectiveness of the intervention studies | Describe the changes occur in the reviewed studies as measures of the effectiveness of the intervention (eg, change in cognitive status, quality of life) | |
| 16. Impact on the study population | Describe the impact on the study population through the quality of life measure post-intervention | |
| 17. Factors supporting intervention | Report on the factors that influence or facilitate the implementation of the interventions in the study reviewed | |
| 18. Factors against intervention | Report on the factors that prevent the implementation of the interventions reported in the review |
BMI, body mass index; PWS, Prader–Willi Syndrome.